Wall Street Analysts Predict a 31% Upside in Agilent (A): Here's What You Should KnowZacks Investment Research • 05/26/22
Agilent Technologies Inc. (A) CEO Mike McMullen on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/25/22
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Cervical CancerBusiness Wire • 05/10/22
Agilent Joins the National Institute for Innovation in Manufacturing to Advance BiomanufacturingBusiness Wire • 04/19/22
Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022Business Wire • 04/08/22
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC)Business Wire • 04/05/22
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell CarcinomaBusiness Wire • 04/05/22
Arima Genomics Closes Series B Financing to Support Growing Portfolio of 3D Genomics Solutions for Biomedical Research and Translational ApplicationsBusiness Wire • 03/15/22
Agilent Announces the 2022 Darlene Solomon Award Presented to Grenoble Alpes University Hospital Scientist Dr. Federica FioriniBusiness Wire • 03/10/22